Baijuguoxi, today is the last day of 2017 to.2017 is not only a national medicine policies continue to fall to benefit the livelihood of the bumper, and major pharmaceutical companies "continuous technological innovation important feudal lords vying for the throne" node. According to statistics, not including the rules of the various provinces and cities issued the 2017 national release has been more than 300 a covering Pharmaceutical, medical, health care and circulation of the four areas under the direction of almost all of the segments. The development of Chinese medicine "13th Five-Year" planning for the first time > Chinese medicine industry to enhance the "national economy important pillar industries" status, in the main business income of Chinese Enterprises above the scale of 12th Five-Year "period increased from 317 billion 200 million yuan to 786 billion 700 million yuan, an average annual increase of 19.92%.
This article will take the traditional Chinese medicine leading enterprise Kangmei pharmaceutical industry as an example to review its development trend in 2017 with eight keywords and to forecast the development trend and path of traditional Chinese medicine industry with its sample.
Key words: Policy bonus! The "God fit" of Kangmei pharmaceutical industry and the development of health service industry
On July 1 , 2017 , the traditional Chinese medicine law was formally implemented , and the important position of the Chinese medicine industry was clarified in the form of law , and the reform and innovation of the existing management system was carried out in the first half of August . In the first half of the year , the company strengthened the " wisdom " big health care system . In the first half of 2017 , the company strengthened the " wisdom " health care system . In the first half of 2017 , the company strengthened the participation of the public hospital reform , played a multi – party advantage , promoted the double – win cooperation , established the new modality of medical industry cooperation , acquired the medical resources of the central hospital of Kaiyuan City , and seized the medical terminal market .
Ma Xingtian, a pioneer in Kangmei pharmaceutical industry
Key words two: industry standard! "Kangmei pharmaceutical industry first" "intelligent Chinese medicine house > standard" officially released
In December 26th, market supervision administration of Shenzhen Municipality issued a formal technical guide for standardization of Chinese medicine "smart room > (No.: SZDB/Z 283-2017), and the provisions of document implementation since February 1, 2018. This marks the Chinese medicine enterprises Kangmei pharmaceutical initiative and operate more than two years of" smart pharmacy "mode, following the December 8th State Administration of traditional Chinese medicine in the administration of guidance on Issuing on promoting health services and the Internet of Chinese medicine in the development of special recognition and fusion requirements applied in the country after the rise to the pharmacy management official in the wisdom of the industry standard.
Key word three: the year of the weak crown! 20 years of Moulding of Pharmaceutical Enterprises
Kangmei pharmaceutical was founded in 1997, its 20th anniversary year in 2017 to coincide with the.2001 listed in the Shanghai Stock Exchange, the short span of twenty years, the U.S. pharmaceutical has created a miracle: from a number of ten small plants to grow to become the world's top 2000 enterprises, 500 enterprises from several China; single product development to tens of thousands of products. Product series development, national standard setters.
Kangmei pharmaceutical total assets of 177 million yuan from 1997 to 2017 of 58 billion 426 million yuan, an increase of 329 times; the sales income of 82 million yuan from 1997 to 2016 of 21 billion 642 million yuan, an increase of 263 times; tax revenue of 4 million yuan from 1999 to 2016 of 1 billion 494 million yuan, an increase of 373 times; the profit increased from 13 million yuan in 1998 in 2016 3 billion 337 million yuan, an increase of 256 times; the market capitalization of 890 million yuan, in 2015 to become the first breakthrough in hundreds of billions of market capitalization of listed pharmaceutical companies, and then to 2017 up to 106 billion 200 million yuan, an increase of 118 times.
The outstanding achievements of Kang Mei ' s pharmaceutical industry have also been fully recognized by the society and the capital market , becoming the top 50 ingredient index shares , successively gaining the honor of " Asia – Pacific best listed company 50 , China ' s most respected listed company " and so on . All of these achievements are all the Kang Mei people who led by Kang Mei ' s pharmaceutical industry pioneer road , and Xu Dongjin ' s husband and wife .
Key words four: the whole industry chain! Medicine industry and medicine industry take the lead in the whole industry chain of traditional Chinese Medicine
From the beginning of creation , only a few products can be produced , and the business runs through several tens of thousands of products such as traditional Chinese medicine decoction pieces , Chinese patent medicines , western medicines , health foods , foods and the like , and the business runs through the key links in the middle and downstream of the traditional Chinese medicine industry chain ;
As the first large-scale listed company to open up the whole industrial chain of Chinese medicine, Kangmei pharmaceutical is developing into a national standard maker, leader and pioneer of wisdom plus big health with the idea of "big health big platform big data plus big service".
Key words : cultural self – confidence !
The culture of traditional Chinese medicine should go into the family of ordinary people, which requires both the public media and the story of traditional Chinese medicine.
A documentary film, once again let the Chinese medicine into the public view. Kangmei pharmaceutical launched human geography documentary "fam God grass", viewers have to point praise, praise the show the magical charm of Chinese herbal medicine culture.
Among the herbs often used to pieces of fresh herbs, many people forget how they swaying in the breeze. A survey shows that Chinese medicine is considered as one of the representative of the Chinese elements. But at present, there are still a lot of people on the Chinese medicine cultural value and significance of the lack of enough understanding.
How to put the ancestors left us precious wealth inheritance, make good use of Chinese medicine? Need to get out of the fam, Houzhi fertile culture of Chinese medicine, Chinese medicine to further Chinese life, understanding of traditional Chinese medicine in modern life, the understanding of traditional Chinese medicine.
The traditional Chinese medicine into modern society, need to expand the pipeline and the public interaction. Mysterious, mysterious, obscure, most young people is the perception of Chinese medicine at a distance. Therefore artemisinin saved countless people, but we usually do not know until Tu won the Nobel Prize, just as the discovery of the new continent generally surprised. This contrast and it is worth reflection. For traditional Chinese medicine, not only to welcome the media to open the window for people to understand, need to go out of the "mystery" of courage and skill. Have the courage, traditional Chinese medicine in order to more liberal and open attitude to embrace the modern science and technology, modern survival for traditional Chinese medicine; traditional Chinese medicine can understand skills. To show people more popular straightforward colors, blooming new charm, out of the small circle, to expand the circle of friends, harvest more young fans.
Key word six: big single "fall son"! Yunnan, Jilin, Gansu, Anhui and other places "wisdom" big health industry projects landed
Kangmei pharmaceutical's entry into Yunnan Province is one of the contents of the company's development strategy plan. Yunnan has abundant biological resources and unique location advantages, so that Kangmei pharmaceutical has signed a cooperation agreement with Puer, Baoshan, Lijiang, Kunming and Wenshan in recent years.
Kangmei pharmaceutical and Kunming municipal government signed an investment cooperation agreement, to speed up the pace of the last sub cloth since the U.S. pharmaceutical Yunnan. The author from Yunnan Province Investment Cooperation Bureau, the U.S. pharmaceutical since 2015, has been in Yunnan and Kunming, Baoshan, Wenshan, Pu'er, Lijiang has signed an investment cooperation agreement.
With the chairman of the U.S. pharmaceutical, said general manager Ma Xingtian, the U.S. pharmaceutical Yunnan layout, is one of the strategic planning the development of the company, Yunnan rich biological resources, unique geographical advantages to Kangmei pharmaceutical industry in recent years, with Baoshan, Lijiang, Pu'er, Kunming, Wenshan signed a cooperation agreement.
The industry is concerned that this year, Kangmei pharmaceutical has signed investment cooperation agreements in Baoshan, Lijiang and Kunming respectively. Investment cooperation projects involve "Kangmei health city" and Chinese herbal medicine planting base, trading center, medical and health services and so on.
In May , Kangmei Pharmaceutical Co . , Ltd . signed an investment cooperation and investment cooperation framework agreement with Baoshan and Tengchong , respectively , covering medical investment , healthy town and so on .
In August, the U.S. pharmaceutical and Lijiang signed a cooperation framework agreement, cooperation projects for medical, health town and planting. Two months later, the U.S. pharmaceutical investment cooperation in the continuous efforts, in October 19th, the team led by Ma Xingtian investment cooperation agreement with the Kunming municipal government signed a total investment of about 8 billion yuan.。
Key words seven: precision poverty alleviation! 5 billion "big gift bag" aimed at the high health and precision poverty alleviation
Kangmei pharmaceutical new headquarters building
In December 4th, the U.S. pharmaceutical Limited by Share Ltd signed a strategic cooperation agreement with the Guizhou Provincial People's government, the U.S. pharmaceutical plans to invest about 5 billion yuan, including cooperation in the field of Chinese medicine industry: precise poverty, national health care project, smart pharmacy, modern pharmaceutical logistics extension services, the construction of the medical conjoined medical health big data.
According to the agreement , Kangmei pharmaceutical industry will take advantage of its own resources and the successful implementation of industrial poverty alleviation programs such as Notoginseng Radix and Ginseng Radix , and undertake the rich experience of national industrial poverty alleviation projects . In Guizhou Tongren and other traditional Chinese medicinal materials such as Huangjing and Paris , it will take part in the construction of pro – poor projects in the traditional Chinese medicine industry .
In November 17th, the U.S. pharmaceutical Limited by Share Ltd and the Dingxi Municipal People's government held a strategic cooperation signing ceremony, the two sides will planting in the U.S. pharmaceutical (Dingxi) Industrial Park, public hospital pharmaceutical logistics extension services, the development of all-round cooperation wisdom and traditional Chinese medicine pharmacy service hall and other fields.
According to the agreement, the U.S. pharmaceutical will give full play to the effect of traditional Chinese medicine enterprises, Dingxi city with the precise poverty alleviation policy, with Chinese angelica, Codonopsis, astragalus, Gansu medicine varieties as the focus, the construction of the geoherbs breeding and seedling cultivation base, driven west medicine planting scale, standardization, standardization development Dingxi, lay a solid foundation for the healthy development of the industry, and investment in the construction of "Kangmei pharmaceutical in Dingxi (Dingxi) Industrial Park, to build a set of Chinese herbal medicine, Chinese medicine granule, medicine production, warehousing and logistics as one of the comprehensive Chinese medicinal materials deep processing base, enhance the processing capacity and comprehensive utilization of genuine medicinal materials in Dingxi ability to achieve long medicine revitalization and development, the formation of brand effect.
On May 24 , Kangmei Industrial Investment Holding Co . , Ltd . ( hereinafter referred to as " Kangmei Industry " ) signed a cooperation framework agreement with Mehekou Municipal People ' s Government in Changchun . According to the agreement , both parties will give full play to their respective advantages , actively promote the construction of new urbanization in Meihekou city , build a special " healthy town " , and further assist the development of the major health industry in Meihekou City .
Vice governor of Jilin province Jin Yuhui, Tonghua Municipal Committee, Meihekou municipal Party committee secretary Wang Aiming, Meihekou Municipal People's Congress Chairman Zhao Min, mayor Zhang Heng, Meihekou CPPCC Chairman Liu Huaiyu, Kang Beauty Group Chairman Ma Xingtian, vice chairman Xu Dongjin attended the signing ceremony. The ceremony by the Meihekou Municipal Committee, deputy mayor Dai Cunhe chaired, Meihekou mayor Zhang Heng, Xu Dongjin vice chairman Kang beauty group representing the two sides signed a cooperation framework agreement.
Key word 8: "the busiest King of Medicine"
In October 12th this year, the Hurun Research Institute released the "Hurun Report 2017>, as the U.S. pharmaceutical helm Ma Xingtian with 40 billion 500 million of the wealth in the forty-sixth richest man in Jieyang, Regal first. Xinhuanet.com Guangdong channel has launched the Guangdong listed company chairman TOP20 the most busy list, among them Ma Xingtian, and called by media" the chairman of Guangdong listed companies busy. "According to incomplete data, in just one month, he attended the 5 field investigation and signing will be from the U.S., big or small are remarkable. The total assets of 177 million yuan from 1997 to 2017 of 65 billion 337 million yuan, an increase of 368 times;
Profits grew from 13 million yuan in 1998 to three billion three hundred and thirty-seven million yuan in 2016, an increase of 256-fold;
The market value of listed companies rose by 118 times as much as $ 106.2 billion in 2017 from $ 8.9 billion in 2001 to $ 10 billion for the first time in 2015 , becoming the first pharmaceutical listed company to break the billion market value in China ' s capital market .
Over the past 20 years, the total tax paid for the country has exceeded 7 billion 700 million yuan, and more than 10000 jobs have been created directly in.2016. The tax paid by this company is only 1/4 higher than that of Puning.
From 1997 to 2017 , the pharmaceutical industry of Kangmei developed rapidly and became a flag of the health industry of Chinese national medicine , which ranked the global enterprise 2000 strong and the Chinese enterprise 500 strong .
No more words, no more than what the figures can explain this private enterprise made in just 20 years. And this dazzling achievement behind the achievement is not difficult to imagine the "King" of a busy degree.
For the future of Kang Mei ' s pharmaceutical industry , Mr . Ma Xingtian has a clear plan and a sense of responsibility . When the market value of Kang Mei ' s pharmaceutical industry breaks through hundreds of billion yuan , Mr . Ma Xingtian is taking part in a party . When he is idle , he opens his cell phone software , and sees the company breaking through the market value of the billion yuan . He doesn ' t even smile . He just looks for a chair and sits quietly .
"I think the burden on shoulders is getting heavier and heavier." Ma Xingtian said, in addition to giving himself pressure, he should take into account the interests of investors, taking into account the future of more than 10 thousand employees.
He was pleased and appreciated that market institutions and the industry ' s experts were rather bullish about the future of the drug industry .
Many organizations publish research reported, both in the pharmaceutical industry in comparison, or from their own point of view, the company still has significantly improved the overall market value of the future space. Zhang Boli said, now the construction of the traditional Chinese medicine for health China just unfolding, with health Chinese. Not just in time, the U.S. pharmaceutical will do better.
2018, the future, has come!
本文来自网络，不代表纪实资讯立场，转载请注明出处。
